BamSEC and AlphaSense Join Forces
Learn More

Bradley Pharmaceuticals Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 10-Q ~1 page Amendment, Extension and Novation of Core Distribution Agreement by and Between McKesson Corporation and Bradley Pharmaceuticals, Inc
12/34/56
EX-10.2
from 10-Q ~5 pages Amendment to Distribution Services Agreement
12/34/56
EX-10.1
from 8-K ~20 pages Employment Agreement
12/34/56
EX-10.16
from 10-K ~20 pages Portions of This Exhibit Have Been Omitted Pursuant to a Request for Confidential Treatment. the Omitted Portions, Marked by [***], Have Been Separately Filed With the Securities and Exchange Commission. Exclusive Sublicense Agreement
12/34/56
EX-10.3.6
from 10-K ~5 pages Fifth Amendment to Distribution Agreement
12/34/56
EX-10.3.5
from 10-K ~5 pages Fourth Amendment to Distribution Agreement
12/34/56
EX-10.1
from 8-K >50 pages Collaboration and License Agreement Between Medigene AG a Public Corporation Under the Laws of the Federal Republic of Germany and Bradley Pharmaceuticals, Inc. a Corporation Under the Laws of Delaware, U.S.A
12/34/56
EX-10.1
from 8-K ~20 pages Licensing and Distribution Agreement by and Between Bradley Pharmaceuticals, Inc. and Par Pharmaceutical, Inc. * * * Doxycycline Monohydrate * * * December 13, 2005
12/34/56
EX-10.5
from 8-K ~10 pages Change of Control Agreement
12/34/56
EX-10.4
from 8-K ~20 pages Employment Agreement
12/34/56
EX-10.3
from 8-K ~20 pages Employment Agreement
12/34/56
EX-10.2
from 8-K ~20 pages Employment Agreement
12/34/56
EX-10.1
from 8-K ~20 pages Employment Agreement
12/34/56
EX-10.1
from 8-K ~5 pages McKesson Corporation Core Distribution Agreement
12/34/56
EX-10.1
from 8-K ~5 pages Forbearance Agreement
12/34/56
EX-10.6
from 8-K ~10 pages Distribution Services Agreement
12/34/56
EX-10.5.4
from 10-Q ~20 pages Deed of Consent and Novation
12/34/56
EX-10.5.3
from 10-Q ~20 pages Jagotec AG (1) Bioglan Pharma PLC (2) Bioglan Pharma Inc (3) Quintiles Ireland Limited (4) Quintiles Transnational Corp (5) Deed of Variation and Novation
12/34/56
EX-10.5.2
from 10-Q ~10 pages Confidential Portions of This Document Have Been Omitted and Filed Separately With the Commission. the Omitted Portions Have Been Marked as Follows: “***”. Second Addendum
12/34/56
EX-10.5.1
from 10-Q ~5 pages Addendum Agreement
12/34/56